Wellspect Surity portfolio gains U.S. Medicare reimbursement access

Go back to Wellspect Surity portfolio gains U.S. Medicare reimbursement access

Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio

October 7, 2026 8:34 AM EDT

Traditional Medicare reimbursement supports broader access to non-invasive management options for eligible beneficiaries living with permanent urinary incontinence

MLNDAL, Sweden, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Wellspect HealthCare today announced that the Surity portfolio, including the Surity Urinary Management System and Surity Female and Male External Catheters, may be covered by traditional Medicare for eligible beneficiaries when medically necessary. This milestone represents an important step in expanding access and reducing barriers to at-home management for people affected by severe urinary incontinence in the U.S.

The Surity portfolio provides... More